Crossmark

Pulmonary arterial compliance as a long-term prognostic indicator in pulmonary arterial hypertension associated with adult congenital heart disease: results from a National multicenter prospective registry

Crossref DOI link: https://doi.org/10.1186/s12872-025-05230-5

Published Online: 2025-10-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Qimou

Yu, Hongrui

Xiong, Changming

Gu, Qing

Yu, Zaixin

Liu, Yuhao

Wu, Weifeng

Zhu, Xianyang

Han, Huijun

He, Jianguo
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400, No. 2016YFC1304400)

China Key Research Projects of the 11th National Five-Year Development Plan (2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07, 2006BAI01A07)

China Key Research Projects of the 12th National Five-Year Development Plan (No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15, No. 2011BAI11B15)
License Information

Text and Data Mining valid from 2025-10-14

Version of Record valid from 2025-10-14
More Information

Article History

Received: 3 July 2025

Accepted: 22 September 2025

First Online: 14 October 2025

Declarations

:

: All enrolled patients had provided written informed consent. The study adhered to the ethical guidelines of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Fuwai Hospital (Approval No.2009 − 208).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below